CN Patent

CN101316590B — 血管生成抑制剂和c-kit激酶抑制剂的组合使用

Assigned to Sanitary Material R&d Management Co ltd · Expires 2011-08-03 · 15y expired

What this patent protects

本发明涉及血管生成抑制剂和c-kit激酶抑制剂的组合使用。本发明的课题在于发现一种显示优异的抗肿瘤效果的药物组合物和癌症治疗方法。4-(3-氯-4-(环丙基氨基羰基)氨基苯氧基)-7-甲氧基-6-喹啉甲酰胺及其类似化合物通过与具有c-kit激酶抑制活性的物质组合使用，可以显示优异的抗肿瘤效果。

USPTO Abstract

本发明涉及血管生成抑制剂和c-kit激酶抑制剂的组合使用。本发明的课题在于发现一种显示优异的抗肿瘤效果的药物组合物和癌症治疗方法。4-(3-氯-4-(环丙基氨基羰基)氨基苯氧基)-7-甲氧基-6-喹啉甲酰胺及其类似化合物通过与具有c-kit激酶抑制活性的物质组合使用，可以显示优异的抗肿瘤效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN101316590B
Jurisdiction
CN
Classification
—
Expires
2011-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.